Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Upbeat Roche bests rival Novartis as new drugs fuel growth

      Upbeat Roche bests rival Novartis as new drugs fuel growth

      Ruby Khatun Khatun27 July 2018 9:30 AM IST
      ZURICH: Swiss drugmaker Roche outshone crosstown rival Novartis by boosting its 2018 sales outlook, helped by new medicines in a year when many feared...
      Tata Trusts launches nationwide hunt for healthcare entrepreneurs

      Tata Trusts launches nationwide hunt for healthcare entrepreneurs

      Ruby Khatun Khatun26 July 2018 3:12 PM IST
      The program aims to foster innovation and entrepreneurship to solve key healthcare challenges and achieve health equity in IndiaNew Delhi: Social...
      Sun Pharma launches generic Glumetza tablets in US

      Sun Pharma launches generic Glumetza tablets in US

      Ruby Khatun Khatun26 July 2018 10:22 AM IST
      New Delhi: Sun Pharmaceutical Industries to said one of its wholly-owned subsidiaries has launched generic metformin hydrochloride extended-release...
      GSK Pharma Q1 profit at Rs 88.59 crore

      GSK Pharma Q1 profit at Rs 88.59 crore

      Ruby Khatun Khatun26 July 2018 10:10 AM IST
      New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) reported a standalone net profit of Rs 88.59 crore for the first quarter of the current fiscal.It had...
      IRDAI for minimising exclusions in health insurance policy

      IRDAI for minimising exclusions in health insurance policy

      Ruby Khatun Khatun26 July 2018 10:00 AM IST
      New Delhi: In a significant consumer-friendly move, insurance regulator IRDAI said it has started the exercise to minimize the number of...
      FDA panel votes against approval of GSKs lung disease drug

      FDA panel votes against approval of GSK's lung disease drug

      Ruby Khatun Khatun26 July 2018 9:45 AM IST
      WASHINGTON: A U.S. Food and Drug Administration expert panel on Wednesday did not support approval of GlaxoSmithKline Plc’s (GSK) drug Nucala in...
      China launches nationwide vaccine sector inspection after scandal

      China launches nationwide vaccine sector inspection after scandal

      Ruby Khatun Khatun26 July 2018 9:30 AM IST
      Beijing: China's drug regulator said it has launched a nationwide inspection of vaccine production as authorities step up the response to a fraud case...
      Not a Single Case of bad quality generic medicines in India: Minister tells Lok Sabha

      Not a Single Case of bad quality generic medicines in India: Minister tells Lok Sabha

      Ruby Khatun Khatun25 July 2018 5:10 PM IST
      New Delhi: Despite countless allegations that generic medicines that are being sold in the country lack any control and hence are of poor quality,...
      Ceiling of drug prices helped save Rs 11,463 crore to public: Govt

      Ceiling of drug prices helped save Rs 11,463 crore to public: Govt

      Ruby Khatun Khatun25 July 2018 10:30 AM IST
      New Delhi: The government said fixation of ceiling prices of medicines has resulted in a saving of Rs 11,463 crore to the public after the...
      Alkem Labs gets EIR from USFDA for its Daman facility

      Alkem Labs gets EIR from USFDA for its Daman facility

      Ruby Khatun Khatun25 July 2018 10:15 AM IST
      New Delhi: Drug firm Alkem Laboratories said the US health regulator has issued an establishment inspection report (EIR) for its Daman...
      Sanofi Ventures leads 17 million dollars financing of Click Therapeutics

      Sanofi Ventures leads 17 million dollars financing of Click Therapeutics

      Ruby Khatun Khatun25 July 2018 10:00 AM IST
      CAMBRIDGE, Mass. & NEW YORK: Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments,...
      Granules India Q1 net profit up 41 percent to Rs 51.7 crore

      Granules India Q1 net profit up 41 percent to Rs 51.7 crore

      Ruby Khatun Khatun25 July 2018 10:00 AM IST
      New Delhi: Drug firm Granules India reported a 40.73 percent rise in its consolidated net profit at Rs 51.79 crore for the quarter ended on June 30,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok